- Home
- GIFT vs MIRA Comparison
GIFT vs MIRA Comparison
Compare GIFT & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GIFT
- MIRA
- Stock Information
- Founded
- GIFT 1999
- MIRA 2020
- Country
- GIFT United States
- MIRA United States
- Employees
- GIFT N/A
- MIRA N/A
- Industry
- GIFT Catalog/Specialty Distribution
- MIRA Biotechnology: Pharmaceutical Preparations
- Sector
- GIFT Consumer Discretionary
- MIRA Health Care
- Exchange
- GIFT Nasdaq
- MIRA Nasdaq
- Market Cap
- GIFT 33.9M
- MIRA 27.7M
- IPO Year
- GIFT N/A
- MIRA 2023
- Fundamental
- Price
- GIFT $1.17
- MIRA $1.67
- Analyst Decision
- GIFT Strong Buy
- MIRA
- Analyst Count
- GIFT 1
- MIRA 0
- Target Price
- GIFT $4.00
- MIRA N/A
- AVG Volume (30 Days)
- GIFT 116.1K
- MIRA 8.8M
- Earning Date
- GIFT 11-12-2025
- MIRA 11-11-2025
- Dividend Yield
- GIFT N/A
- MIRA N/A
- EPS Growth
- GIFT N/A
- MIRA N/A
- EPS
- GIFT N/A
- MIRA N/A
- Revenue
- GIFT $90,569,384.00
- MIRA N/A
- Revenue This Year
- GIFT $5.90
- MIRA N/A
- Revenue Next Year
- GIFT $13.45
- MIRA N/A
- P/E Ratio
- GIFT N/A
- MIRA N/A
- Revenue Growth
- GIFT 8.55
- MIRA N/A
- 52 Week Low
- GIFT $0.82
- MIRA $0.73
- 52 Week High
- GIFT $2.38
- MIRA $2.56
- Technical
- Relative Strength Index (RSI)
- GIFT 58.88
- MIRA 61.93
- Support Level
- GIFT $1.05
- MIRA $1.36
- Resistance Level
- GIFT $1.18
- MIRA $2.45
- Average True Range (ATR)
- GIFT 0.07
- MIRA 0.17
- MACD
- GIFT 0.00
- MIRA 0.02
- Stochastic Oscillator
- GIFT 71.05
- MIRA 35.00
About GIFT RDE Inc. Common Stock
Giftify Inc through its wholly-owned subsidiary, has been in the business of connecting digital consumers, businesses and communities with dining and merchant deal options throughout the United States. The company connects digital consumers, businesses, and communities offering dining and merchant deal options nationwide restaurants, and retailers to customers. The Company buys merchant gift cards from the general public and distributors at a discount and then resells them at a markup.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.